This case study highlights how we engineered a scalable, patient-centric pharmacy solution for Eli Lilly’s immunology pilot, validating new high-touch fulfillment and payer coordination models.
LAUNCH TIMELINE
12-week delivery
PLATFORM SCALABILITY
100% multi-tenant readiness
Truepill (now operating under the Fuze Health umbrella) provides an API-first platform that enables pharmaceutical brands, telehealth providers, and health insurers to launch and scale national pharmacy experiences. By combining a digital healthcare platform with a physical network of high-tech fulfillment centers, the company streamlines the test-to-treat process for millions of patients.
Our partnership first began when Truepill engaged the Codal team to build a new platform that would enable pharmaceutical companies to connect with buyers, educate them on certain drugs, and then sell and deliver the products directly. The goal was to cut out distributors, logistics services, and other middlemen out of the process.
The impact of the new platform was seen right away: pharma companies were empowered to better communicate with their customers, offer more competitive pricing, and speed up delivery times. Our team was able to deliver the new platform quickly and seamlessly, showcasing our ability to succeed on tight timelines and in areas where internal teams have previously struggled.
Several years later and following a major internal reorganization, TruePill evolved into Fuze Health, a healthtech system that also includes Alto Health (women’s health), LetsGetChecked (at-home diagnostics), and TruePill (general pharmacy). While there was a change in leadership and entity structure, Codal was re-engaged when additional requirements came about.
The new leaders were briefed on our capabilities and previous successful delivery and trusted us to execute the next phase of their digital roadmap.
Our partnership with Fuze Health deepened through an on-site visioning workshop where key members of our healthcare strategy team and their stakeholders explored the future of virtual pharmacy. We identified that the company’s primary roadblock to growth was scalability. Every time they signed a new pharmacy partner, they had to manually build a new virtual storefront, wasting valuable time and resources that could be used elsewhere.
The goal was clear. Fuze Health needed a multi-tenant architecture to allow a single framework to support a multitude of different partner instances.
The immunology pilot project launched as a result of the visioning workshop. Fuze Health wanted to expand into the specialty drug space and its new partnership with Eli Lilly was the prime opportunity.
With Codal as the consultant and technical lead, Fuze Health and Eli Lilly sought to co-develop and validate a scalable, patient-centric pharmacy solution tailored to complex specialty immunology therapies. The initiative served as the foundational step to provide partner pharmacies with a seamless, high-touch experience across fulfillment, payer coordination, and patient engagement.
To meet the market demands for these new therapies, the project was set with a high-stakes, pre-defined timeline of 10 to 12 weeks. Our team immediately got to work leading a mini discovery to refine the exact product requirements. Through various working sessions, we translated the existing high-level business requirements into a granular technical PRD (product requirement document). By establishing the blueprint, our team was able to navigate the aggressive timeline with a clear roadmap.
We provided end-to-end support across the full tech stack: backend (Node.js), frontend (React.js), QA (Playwright), and CMS (Contentful). Other key features and functionalities include:
The immunology pilot project successfully transformed a high-touch, manual process into a flexible, scalable eCommerce ecosystem. We delivered all requirements within the strict 12-week deadline.
The impact was immediately felt across the patient and provider journey. With the new appeal status tracker, patients now have real-time visibility into the insurance process, which helps reduce the anxiety and administrative friction often associated with high-cost specialty drugs. The internal drug savings API lowers the barrier to treatment for new-to-market therapies, thanks to the automatically served virtual cards. And the introduction of multi-tenancy empowers Fuze Health to manage complex, drug specific messaging and fulfillment without the need for a total system rebuild.
While we delivered successful code, what truly defines the success of this engagement was the operational mentorship we provided throughout the process. In addition to building and shipping features, we helped Fuze Health mature their internal engineering culture. We helped optimize their Jira environment and implemented rigorous code review and status reporting workflows.
Because documentation for the existing system was light and knowledge of the various APIs was dispersed across the organization, our developers worked in lockstep with different members of their engineering team in real time to bridge these gaps and compile the technical requirements necessary for integration.
Fuze Health applauded our collaborative project management style that prioritizes transparency and careful documentation. The pilot project concluded with our team teaching their internal teams how to replicate our organizational efficiency.
Building on the momentum achieved, our partnership has transitioned into a third phase: modernizing Fuze Health’s electronic medical record system (EMR).
The ongoing project focuses on a high-impact community and support program in partnership with United Healthcare (UHC). The system is designed to identify and support patients immediately following an ER discharge, automatically connecting them with clinicians for critical behavioral health programs and suicide prevention services. We are applying the same multi-tenant philosophy established in the immunology pilot to ensure the new EMR is flexible enough to scale across all of Fuze Health’s future clinical programs.
With a main target of 25% of contacted patients completing a clinical assessment, the initiative represents the next step in our shared mission to create a more connected, responsible, and patient-centric healthcare experience.
If this case study sparked ideas, let’s talk. From strategy and experience design to unified commerce and product engineering, Codal helps ambitious brands turn vision into reality.
